Eyepoint Pharmaceuticals (NASDAQ:EYPT) outlined late-stage clinical progress for its lead retinal candidate DURAVYU and ...
Dosing completed in Phase 1 study of budoprutug subcutaneous formulation, with data expected in H1 2026 Budoprutug clinical trials ongoing in pMN, ITP, and SLE, with initial data from all three trials ...
A few months into GLP-1 treatment, many patients encounter an unexpected and distressing side effect: significant hair loss.
Oncology projects currently take up about 40% of Pfizer’s overall R&D budget. | After steering positive key pivotal readouts for a trio of Novartis’ blockbusters, Jeff Legos is now tasked with ...
When WSDOT closed two lanes of the northbound 1st Avenue South Bridge after an inspection revealed problems 2+ weeks ago, an update was promised by this Friday. Today, we have it - a repair plan ...
The U.S. Bureau of Reclamation has launched a challenge to stop invasive mussels that cost more than $1 billion a year.
Taylor Farms donated $1.5 million to the Salinas Regional Soccer Complex, launching 'The Match' a $3M campaign for new soccer fields and amenities.
Gold prices have surged about 20% so far this year, notching successive record highs amid heightened global political and ...
Central Minnesota cities seek state bonding funds for river access, road upgrades and economic development projects.
HUTCHMED divested a 45.0% equity interest in SHPL for $608.5 million in cash in April 2025, retaining a 5.0% equity interest. As a result, HUTCHMED’s share of equity in earnings of SHPL in 2025 ...
Malls in south-central Pennsylvania run the gamut. There’s the Capital City Mall, which has more than 100 tenants and no interior vacancies. And there’s the York Galleria Mall, which welcomed a casino ...
The companies Vaxcyte, Generate Biomedicines, and Immunic bagged the biggest biotech funding rounds overall in February 2026.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results